• Home
  • Useful Internet Links
CAMPHARM - Helping to bring medicines and other healthcare products to patients and consumers quicker
  • ServicesWhat We Do
    • Legal Representation Outside EU
    • Regulatory Strategy
    • Regulatory Intelligence
    • Scientific Data Assessment
    • Regulatory Project Management
    • Registration Applications
    • Regulatory Procedures
    • Regulatory Agency Meetings
    • Technical Support for Litigation
    • Technical & Management Training
    • Due Diligence Projects
    • Licensing Partner Searches
    • Organisation Re-engineering
    • Pharmacovigilance & RM
    • Other Services
  • Who We AreCompany Information
  • NewsCompany News
  • ContactGet in Touch
    • Contact Us
    • Jobs at CAMPHARM

Gallery

HomeGallery

 

CAMPHARM Twitter

  • Brexit or no Brexit, it's an EMA Exit https://t.co/RUeAOUart0 2 years ago
  • MHRA responds to consultation on Brexit no-deal proposals https://t.co/L0auFn4XBd 2 years ago
  • MHRA responds to consultation on Brexit no-deal proposals https://t.co/0Tlfm2DkA2 2 years ago
  • UK medicines agency head to step down in 2019, as Brexit looms https://t.co/qGx492oCBA 2 years ago
  • UK drugs regulator consults on ‘no deal’ Brexit arrangements https://t.co/eVWpQBgsxa via @pharmaphorum 3 years ago
Follow @CAMPHARM

RSS Pharmatimes

  • New subcutaneous formulation of Tysabri approved in UK
  • EMA begins review of GSK/Vir’s COVID-19 antibody
  • Roche’s SMA treatment Evrysdi demonstrates continued improvements in infants
  • NICE recommends Alexion’s PNH treatment Ultomiris
  • Alchemab completes £60m Series A funding to advance novel antibody platform

Follow Us

  • RSS
  • Twitter
  • Facebook
  • LinkedIn
 

Copyright © 2012 CAMPHARM IT Ltd Registered at Companies House Cardiff: 05487669
Registered Office: 11 Queens Road, Brentwood, Essex, CM14 4HE

top
  • Home
  • Sitemap
  • News